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Introduction. Subjective cognitive impairment (SCI), depressive symptoms, and fatigue are common after stroke and are associated
with reduced quality of life. We prospectively investigated their prevalence and course after a transient ischemic attack (TIA) or
nonfocal transient neurological attack (TNA) and the association with diﬀusion-weighted imaging (DWI) lesions. Methods. The
Cognitive Failures Questionnaire, Hospital Anxiety and Depression Scale, and Subjective Fatigue subscale from the Checklist
Individual Strength were used to assess subjective complaints shortly after TIA or TNA and six months later. With repeated
measure analysis, the associations between DWI lesion presence or clinical diagnosis (TIA or TNA) and subjective complaints
over time were determined. Results. We included 103 patients (28 DWI positive). At baseline, SCI and fatigue were less severe in
DWI positive than in DWI negative patients, whereas at follow-up, there were no diﬀerences. SCI (p = 0 02) and fatigue (p =
0 01) increased in severity only in DWI positive patients. There were no diﬀerences between TIA and TNA. Conclusions.
Subjective complaints are highly prevalent in TIA and TNA patients. The short-term prognosis is not diﬀerent between DWI-
positive and DWI negative patients, but SCI and fatigue increase in severity within six months after the event when an initial
DWI lesion is present.
1. Introduction
Subjective cognitive impairment (SCI), depressive symp-
toms, and fatigue are highly prevalent after stroke and are
related to stroke severity [1–4]. Although by deﬁnition the
symptoms of a transient ischemic attack (TIA) subside
completely within 24 hours [5], subjective cognitive com-
plaints, depressive symptoms, and fatigue often persist in
these patients as well [6–8].
Diagnosing TIA is notoriously diﬃcult [9]. Patients often
report attacks of atypical or nonfocal neurological symptoms.
In the absence of an alternative diagnosis, these episodes are
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referred to as transient neurological attack (TNA) [10]. In
one-third of TIA patients, diﬀusion-weighted imaging
(DWI) shows signs of acute ischemia beyond the point
of symptom resolution, ascertaining a cerebrovascular eti-
ology of the attack [11]. Acute DWI lesions are however
also present in more than 20% of clinically diagnosed
TNA patients [12].
Previous studies on subjective complaints after short-
lasting attacks of neurological symptoms have focused solely
on TIA, did not take DWI ﬁndings into account, and were
cross-sectional in nature [6–8]. Since subjective complaints
are associated with a reduced quality of life and are possible
harbingers of forthcoming cognitive decline, it is important
to understand their prevalence and determinants [13, 14].
We prospectively investigated the prevalence, severity,
and course of SCI, depressive symptoms, anxiety, and fatigue
in a cohort of TIA and TNA patients and determined the
relation with event type and DWI results. We hypothesized
that patients with acute DWI lesions would report an
increase in severity of complaints in the months after the ini-
tial event. Since TIA and TNA have a comparable prevalence
of DWI positivity, we expected to ﬁnd no diﬀerences between
these patient categories [12].
2. Methods
2.1. Study Design and Patients. This study was part of the
prospective Cohort study ON Neuroimaging, Etiology, and
Cognitive consequences of Transient neurological attacks
(CONNECT), the details of which have been previously
reported [15]. Consecutive stroke-free patients aged≥ 45
years referred to a specialized outpatient TIA clinic within
7 days after an event of acute onset neurological symptoms
lasting< 24 hours were included. Baseline measurements
took place within seven days after the qualifying event, and
follow-up was performed six months later. All baseline
assessments were performed before the ﬁnal diagnosis was
discussed with the patient. The Medical Review Ethics Com-
mittee region Arnhem-Nijmegen approved the study, and
written informed consent was obtained from all participants.
2.2. Classiﬁcation of Qualifying Event. Based on a detailed
description of the signs and symptoms of the event including
a structured assessment of the presence or absence of eigh-
teen speciﬁc predeﬁned symptoms (Table 1), three special-
ized stroke neurologists adjudicated each event as TIA,
TNA, or a speciﬁed other diagnosis, using previously deter-
mined deﬁnitions of TIA and TNA [5, 10]. Events with both
focal and nonfocal symptoms were classiﬁed as TIA. Qualify-
ing neurologists were blinded to results from MRI, and in
case of disagreement, a consensus meeting was held.
2.3. Brain Imaging. Brain MRI was performed within seven
days after the qualifying event on a 1.5 Tesla Magnetom
Scanner (Siemens, Erlangen, Germany) and included DWI,
FLAIR, T1-, T2-, and T2∗-weighted sequences. Two experi-
enced raters individually evaluated the severity of white mat-
ter hyperintensities, the presence of (silent) territorial
infarcts, lacunes, and microbleeds [16, 17]. DWI was visually
assessed for signs of acute infarction. Raters were unaware of
clinical information, and a consensus meeting was held in
case of disagreement.
2.4. Subjective Cognitive Impairment. At baseline and fol-
low-up, the presence and severity of SCI in the previous
month was assessed with a 15-item semistructured interview
based on the Cognitive Failures Questionnaire (CFQ) [18].
Items concerning remembering, word ﬁnding, planning,
concentration, and slowness of thought were given a wider
score range (0–3) than other items (0-1). SCI was consid-
ered present if ≥1 moderate problem (score≥ 2) on an item
with a score range of 0 to 3 or a score of 1 on a dichotomous
item was reported [19]. Trained examiners, unaware of clin-
ical diagnosis and DWI status, administered all semistruc-
tured interviews.
2.5. Other Measurements. At both baseline and follow-up, the
Hospital Anxiety and Depression Scale (HADS) was admin-
istered to measure the severity of symptoms of depression
and anxiety [20]. Relevant symptoms of depression or anxi-
ety were deﬁned as a value of >7 on the subscales [21].
Fatigue was assessed with the subscale Subjective Fatigue of
the Checklist Individual Strength (CIS20R-fatigue) with a
score> 35 considered indicative for severe fatigue [22]. Level
of education was classiﬁed using seven categories (1= less
than primary school; 7 = academic degree) [23]. Vascular risk
factors were assessed at baseline. Incident vascular events
(stroke, TIA, and myocardial infarction) between baseline
and follow-up were assessed with a standardized, structured
questionnaire. All questionnaires were handed out at the
baseline or follow-up visit. In case of limited time, these were
ﬁlled in at home and returned within one week.
2.6. Statistical Analysis.Only patients who completed follow-
up were included. Baseline characteristics were compared
between patients with complete and incomplete follow-up,
between TIA and TNA between patients, and patients with
and without DWI lesion, using Student’s t-test, χ2 test, or
Mann–Whitney U test as appropriate.
Table 1: Predeﬁned focal and nonfocal neurological symptoms.
Focal Nonfocal
Hemiparesis
Decreased consciousness or
unconsciousness
Hemihypesthesia Confusion
Dysphasia Amnesia
Dysarthria Unsteadiness
Hemianopia Nonrotatory dizziness
Transient monocular
blindness
Positive visual phenomena
Hemiataxia Paresthesias
Diplopia Bilateral weakness of arms or legs
Vertigo Unwell feelings∗
Symptoms should have sudden onset, rapid clearance, and duration of
<24 hours. ∗Referable to the nervous system if the referring physician
considered TIA but patients were unable to specify further.
2 Behavioural Neurology
Diﬀerences in prevalence of SCI, symptoms of depression
or anxiety, and severe fatigue between groups (clinical
diagnosis and DWI status) and time points were analyzed with
McNemar’s test. Subsequently, the eﬀect of DWI lesion and
clinical diagnosis on change in subjective outcomes over time
was determined with repeated measures analyses of variance.
Associations between SCI, fatigue, and depressive and anxiety
symptoms were assessed with multivariate regression analysis.
Age, sex, and level of education were regarded as poten-
tial confounders and adjusted for in all repeated measures
analyses. Alpha was set at 0.05 and statistical analyses were
performed with IBM SPSS Statistics version 24.0 (IBM Corp.,
Armonk, NY).
3. Results
CONNECT included 150 patients, 87 of whom were diag-
nosed as TIA, 56 as TNA, and 7 with a speciﬁc diagnosis.
Patients in the last category were excluded from further
analyses, as were those with incomplete baseline or
follow-up assessments, leading to 103 included patients
(Figure 1). Reasons for incomplete assessment were failure
to return questionnaires (>95%) and refusal (<5%). Patients
with incomplete HADS or CIS20R-fatigue were slightly
younger (mean 61.8 [SD 10.7] years versus 65.8 [SD 9.1]
years, p = 0 04) than those with complete evaluations. There
were no diﬀerences concerning clinical diagnosis, DWI
lesion presence, level of education, or presence of vascular
risk factors between patients with complete and incomplete
assessments. Baseline characteristics of participants with com-
plete assessments are presented by DWI results in Table 2.
DWI lesions were more often present in clinically deﬁned
TIA patients, although 13% of included TNA patients also
had a DWI lesion. Most DWI lesions were small cortical or
subcortical lesions. There were no incident strokes or myocar-
dial infarctions between baseline and follow-up, and ﬁve
patients had an incident TIA. Excluding patients with incident
TIA from the analyses did not change the results.
CONNECT inclusion
N = 150
CIS20R-fatigue
N = 101
HADS
N = 103
CFQ
N = 87
Excluded N = 7
Other diagnosis than
TIA or TNA
Excluded N = 40 
Incomplete
baseline (18)
or follow-up (22)
N = 143
TIA 87; TNA 56
DWI+ 40; DWI− 103
N = 103
TIA 65; TNA 38
DWI+ 28; DWI− 75
Figure 1: Study population. CFQ: Cognitive Failures Questionnaire; CIS20R-fatigue: Checklist Individual Strength, fatigue subscale; DWI:
diﬀusion-weighted imaging; HADS: Hospital Anxiety and Depression Scale; TIA: transient ischemic attack; TNA: transient neurological attack.
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3.1. Subjective Cognitive Impairment (n = 87). The overall
prevalence of SCI in TIA and TNApatients was 82% at baseline
and 77% at follow-up and was not signiﬁcantly diﬀerent
between time points, DWI status, or clinical diagnosis. At base-
line, themean number of subjective cognitive failures was lower
in patients with a DWI lesion than in those without (mean (SD)
1.83 (1.75) versus 3.77 (3.27), p = 0 01), while at follow-up, this
increased to 3.00 (2.70) in the ﬁrst group and decreased slightly
to 3.14 (3.17) in the latter (p = 0 73) (Figure 2(a)). Repeated
measures analysis (adjusted for age, sex, and level of education)
showed that change over time in the number of subjective cog-
nitive failures was signiﬁcantly diﬀerent between DWI positive
and DWI negative patients (p = 0 01). There was no diﬀerence
in SCI between TIA and TNA patients.
3.2. Depressive Symptoms and Anxiety (n = 103). Relevant
depressive symptoms (HADS-depression subscore> 7) were
present in 8% of all patients at baseline and 9% at follow-
up. The prevalence of relevant anxiety symptoms (HADS-
anxiety subscore> 7) was 15% at baseline and 11% at
follow-up. Depressive and anxiety symptoms did not diﬀer
between DWI negative and DWI positive patients or between
TIA and TNA patient groups (Figures 2(b) and 2(c)).
3.3. Fatigue (n = 101). Severe fatigue (CIS20R-fatigue
score> 35) was present in 23% of patients at baseline and in
19% six months later. Prevalence of severe fatigue did not
diﬀer between DWI positive and DWI negative patients or
between TIA and TNA patients.
Mean (SD) CIS20R-fatigue score was 25.0 (12.7) at base-
line and 24.8 (11.5) at follow-up. Baseline scores were lower
in DWI positive patients (21.0 (12.7) compared to 26.6
(12.4) for those without; p = 0 07) but equal at follow-up
(24.9 (11.6) in the DWI positive group versus 24.7 (11.6) in
the DWI negative group; p = 0 86). Patients with and without
DWI lesions diﬀered with respect to change in CIS20R-
fatigue scores (p = 0 01) (Figure 2(d)). The clinical diagnosis
was unrelated to severity or change over time of fatigue.
At both baseline and follow-up, SCI was associated with
higher CIS20R-fatigue scores (p = 0 001), but not with symp-
toms of depression or anxiety.
4. Discussion
Subjective complaints, especially SCI and fatigue, are highly
prevalent in TIA and TNA patients both directly before the
event and after six months. The initial qualifying diagnosis
was unrelated to the presence, severity, and course of subjec-
tive complaints. Patients with signs of acute ischemia on
DWI reported less severe SCI and fatigue in the month before
the TIA or TNA than those without such a lesion. In this
group of patients, severity subsequently increased in the six
months after the event to a level equal to that of DWI nega-
tive patients.
Some methodological issues need to be considered when
interpreting these results. First, given the loss to follow-up,
selection bias might have occurred. Patients with missing
follow-up HADS and CIS20R-fatigue assessments were on
average slightly younger than participants. Since especially
fatigue is more often reported in older patients, this might
have resulted in an overestimation of its prevalence [24].
Alternatively, patients with incomplete assessments might
have dropped out because of complaints, resulting in an
underestimation. Other demographic variables however did
not diﬀer between patients with and without complete assess-
ments, and we adjusted for age in our analyses. Therefore, we
feel that selection bias has not largely inﬂuenced our results.
The relatively small patient numbers in our study however
limit statistical power, and our results need to be replicated
in a larger cohort. Secondly, we used questionnaires to obtain
information on the presence of SCI, depression, anxiety, and
fatigue. These screening instruments, although validated,
indicate whether patients experience dysfunction when
actively asked about it. This diﬀers from spontaneously
reported complaints and may explain the high frequency of
SCI observed in our cohort. The CFQ handles a strict cutoﬀ
for SCI, making it a sensitive but perhaps not very speciﬁc
screening instrument. Thirdly, our study did not include a
control group, limiting the interpretation of an added eﬀect
of TIA or TNA on subjective complaints.
The prevalence of SCI in our study is comparable to that
in both stroke patients and those with evidence of small ves-
sel disease on neuroimaging, using the same screening
instrument [2, 19, 25]. Patients in those studies were on aver-
age older, had more often suﬀered stroke instead of TIA, and
were tested several years after the initial event. Also, vascular
Table 2: Baseline patient characteristics stratiﬁed by DWI result
(n = 103).
DWI+
(n= 28)
DWI−
(n= 75)
p∗
Women 8 (29) 29 (39) 0.34
Age, mean (SD) 66.7 (8.5) 65.6 (9.3) 0.60
Level of education, median (IQR) 5 (3) 5 (2) 0.10
TIA 23 (82) 42 (56) 0.01
Hypertension 25 (89) 60 (80) 0.27
Dyslipidemia 18 (64) 53 (71) 0.53
Diabetes mellitus 2 (7) 7 (9) 0.73
Atrial ﬁbrillation 3 (11) 10 (13) 0.72
Smoking 13 (46) 17 (23) 0.02
Diﬀusion-weighted imaging
lesions, total n
45 N/A N/A
Lesion type
Small cortical 26 (58)
Small subcortical 14 (31)
Territorial 5 (11)
Fazekas score, median (IQR) 1 (1) 1 (1) 0.30
Lacunes 5 (18) 12 (16) 0.82
Territorial infarcts 2 (7) 8 (11) 0.59
Microbleeds
(available for 72 patients)
1 (6) 6 (11) 0.49
Values are n (%) unless stated otherwise. ∗For diﬀerence using Student’s t-
test, χ2 test, or Mann–Whitney U test as appropriate. DWI: diﬀusion-
weighted imaging; IQR: interquartile range; TIA: transient ischemic attack;
N/A: not applicable.
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lesions on neuroimaging were relatively sparse in our cohort,
as compared to these studies [19, 25]. The high prevalence of
SCI in TIA and TNA patients is therefore remarkable. Severe
fatigue was less prevalent in our patients than in other stroke
cohorts, as were depressive symptoms [4, 26, 27].
Interestingly, DWI positive patients reported less sub-
jective cognitive failures and fatigue in the month before
the event than those without a lesion. The DWI positive
group by deﬁnition consisted of patients with a recent cere-
brovascular event, independent of the clinical diagnosis.
The DWI negative group possibly included some patients
whose transient complaints have noncerebrovascular causes
such as somatization, depression, or anxiety. Although this
may explain the higher prevalence of premorbid SCI and
fatigue, the lack of observed higher frequencies of depres-
sive or anxiety symptoms does not support this hypothesis.
Furthermore, we found no changes in subjective com-
plaints in the DWI negative group, although one could
expect these to increase after a disturbing event such as a
TIA or TNA.
Within six months after TIA or TNA, severity of SCI and
fatigue increased signiﬁcantly in DWI positive patients. This
can be explained in several ways. First, DWI hyperintensities
are associated with permanent brain damage, which in turn is
associated with cognitive decline, SCI, mood disorders, and
fatigue in stroke patients [1, 3, 4, 28, 29]. Although the exact
etiology remains to be established, a relationship between
minor cognitive decline and recent lacunar infarct has been
suggested [30]. Since the DWI lesions in our cohort were pre-
dominantly small cortical and subcortical lesions, a similar
relationship may exist between these lesions and increasing
subjective complaints over time. Second, the knowledge of
having a DWI lesion could have inﬂuenced the perception
of cognitive performance and have led to more subjective
cognitive complaints. Third, secondary preventive medica-
tions including statins will more often have been started in
the DWI positive patient group. Statins have been associated
with cognitive complaints and fatigue. However, there are no
consistent negative eﬀects of statins on these outcome mea-
sures [31]. Finally, the increase in severity of SCI and fatigue
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Figure 2: Subjective cognitive impairment, depressive symptoms, anxiety symptoms, and fatigue at baseline and follow-up in transient
neurological attack patients with and without diﬀusion-weighted imaging lesions. CFQ: Cognitive Failures Questionnaire; CIS20R-fatigue:
Checklist Individual Strength, fatigue subscale; DWI: diﬀusion-weighted imaging; HADS-a: Hospital Anxiety and Depression Scale,
anxiety; HADS-d: Hospital Anxiety and Depression Scale, depression. ∗p = 0 02, analysis of covariance, adjusted for age, sex, and level of
education. †p = 0 02, ‡p = 0 01, repeated measures analysis for the diﬀerence in change over time between DWI negative and DWI positive
patients, adjusted for age, sex, and level of education.
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observed in the DWI positive patient group could be merely a
correction of an unexplained baseline diﬀerence, that is,
regression towards the mean. However, no changes in preva-
lence or severity of these complaints were found in the DWI
negative group, countering this explanation.
Fatigue was associated with subjective cognitive dysfunc-
tion. Possibly, both fatigue and SCI, as measured in our
study, are expressions of the same underlying sense of
unwell-being. We found no association between depressive
symptoms and subjective cognitive dysfunction, suggesting
that the increased severity of SCI observed in DWI positive
patients was not inﬂuenced by mood changes.
5. Conclusions
Subjective complaints are highly prevalent in TIA and TNA
patients. Larger sampled studies with longer follow-up need
to determine whether subjective complaints last beyond six
months after TIA or TNA and assess the course over time
with respect to DWI lesion presence and the association with
cognitive performance. Furthermore, the etiology of subjec-
tive cognitive impairment and fatigue after short-lasting
cerebral ischemia and the association with radiological
markers of cerebrovascular damage such as lacunes and cere-
bral atrophy should be subject to further research. Our
results nevertheless add to the growing notion that TIA and
TNA are more than just transient attacks but are associated
with ongoing deﬁcits and problems. This can be used to
inform patients on the potential long-term prognosis of their
TIA or TNA.
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